SonoScape Medical has released its 2026 stock option incentive plan, proposing to grant 6.98 million stock options to 322 incentive recipients, accounting for approximately 1.64% of the company's total share capital. The incentive recipients include some directors, senior management, mid-level managers, and technical and business backbone staff, with an exercise price of no less than 20.73 yuan per option. In the first half of 2026, SonoScape Medical achieved revenue of 1.053 billion yuan and net profit attributable to the parent company of 13.78 million yuan.
SonoScape Medical CorpStock option incentive plan aligns management interests and signals confidence, with exercise price above current levels.
